As of 2024-09-08, the EV/EBITDA ratio of AtriCure Inc (ATRC) is -115.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AtriCure's latest enterprise value is 1,226.86 mil USD. AtriCure's TTM EBITDA according to its financial statements is -10.60 mil USD. Dividing these 2 quantities gives us the above AtriCure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.3x - 16.6x | 14.0x |
| Forward P/E multiples | 11.1x - 28.6x | 17.2x |
| Fair Price | (1.41) - (2.56) | (2.34) |
| Upside | -105.4% - -109.8% | -108.9% |
| Date | EV/EBITDA |
| 2024-09-06 | -115.80 |
| 2024-09-05 | -115.34 |
| 2024-09-04 | -115.66 |
| 2024-09-03 | -114.42 |
| 2024-08-30 | -115.66 |
| 2024-08-29 | -113.87 |
| 2024-08-28 | -112.85 |
| 2024-08-27 | -112.85 |
| 2024-08-26 | -115.38 |
| 2024-08-23 | -112.12 |
| 2024-08-22 | -107.11 |
| 2024-08-21 | -105.45 |
| 2024-08-20 | -103.75 |
| 2024-08-19 | -105.27 |
| 2024-08-16 | -104.90 |
| 2024-08-15 | -105.09 |
| 2024-08-14 | -98.74 |
| 2024-08-13 | -98.56 |
| 2024-08-12 | -92.22 |
| 2024-08-09 | -91.30 |
| 2024-08-08 | -93.96 |
| 2024-08-07 | -88.68 |
| 2024-08-06 | -94.28 |
| 2024-08-05 | -93.69 |
| 2024-08-02 | -96.54 |
| 2024-08-01 | -91.89 |
| 2024-07-31 | -94.33 |
| 2024-07-30 | -96.31 |
| 2024-07-29 | -96.12 |
| 2024-07-26 | -96.77 |
| 2024-07-25 | -103.34 |
| 2024-07-24 | -105.45 |
| 2024-07-23 | -108.86 |
| 2024-07-22 | -104.67 |
| 2024-07-19 | -106.28 |
| 2024-07-18 | -108.58 |
| 2024-07-17 | -110.42 |
| 2024-07-16 | -111.48 |
| 2024-07-15 | -104.49 |
| 2024-07-12 | -101.78 |
| 2024-07-11 | -102.70 |
| 2024-07-10 | -97.18 |
| 2024-07-09 | -97.41 |
| 2024-07-08 | -95.57 |
| 2024-07-05 | -103.98 |
| 2024-07-03 | -98.38 |
| 2024-07-02 | -98.10 |
| 2024-07-01 | -98.61 |
| 2024-06-28 | -99.85 |
| 2024-06-27 | -102.24 |